ArticleEuropean radiology2025
Preoperative prediction of malignant transformation in sinonasal inverted papilloma: a novel MRI-based deep learning approach.
Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- AI-Powered TAT-Net Hyperspectral Imaging for Rapid and Accurate Differentiation of Sinonasal Inverted Papilloma and Malignancy.World journal of otorhinolaryngology - head and neck surgery · 2026Article
- Beyond whole-image learning: anatomically partitioned deep learning models for superior sinonasal disease classification.European radiology · 2026Article
- [Skull base surgery-where do we stand?]HNO · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveTo develop a novel MRI-based deep learning (DL) diagnostic model, utilizing multicenter large-sample data, for the preoperative differentiation of sinonasal inverted papilloma (SIP) from SIP-transformed squamous cell carcinoma (SIP-SCC).
methodsThis study included 568 patients from four centers with confirmed SIP (n = 421) and SIP-SCC (n = 147). Deep learning models were built using T1WI, T2WI, and CE-T1WI. A combined model was constructed by integrating these features through an attention mechanism. The diagnostic performance of radiologists, both with and without the model's assistance, was compared. Model performance was evaluated through receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis (DCA).
resultsThe combined model demonstrated superior performance in differentiating SIP from SIP-SCC, achieving AUCs of 0.954, 0.897, and 0.859 in the training, internal validation, and external validation cohorts, respectively. It showed optimal accuracy, stability, and clinical benefit, as confirmed by Brier scores and calibration curves. The diagnostic performance of radiologists, especially for less experienced ones, was significantly improved with model assistance.
conclusionsThe MRI-based deep learning model enhances the capability to predict malignant transformation of sinonasal inverted papilloma before surgery. By facilitating earlier diagnosis and promoting timely pathological examination or surgical intervention, this approach holds the potential to enhance patient prognosis. KEY POINTS: Questions Sinonasal inverted papilloma (SIP) is prone to malignant transformation locally, leading to poor prognosis; current diagnostic methods are invasive and inaccurate, necessitating effective preoperative differentiation. Findings The MRI-based deep learning model accurately diagnoses malignant transformations of SIP, enabling junior radiologists to achieve greater clinical benefits with the assistance of the model. Clinical relevance A novel MRI-based deep learning model enhances the capability of preoperative diagnosis of malignant transformation in sinonasal inverted papilloma, providing a non-invasive tool for personalized treatment planning.
Indexed as
Identifiers
40355636What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.